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Reply to the letter from Rettig and Lemon
Sir - In their letter, Rettig and Lemon raised the possibility
that non-steroidal anti-inflammatory drugs (NSAIDs) may
have contributed to the sex differences in time trends of
colorectal cancer in England and Wales. We agree that this is
an interesting possibility; there are some data available to
examine it. The total number of prescriptions (excluding
preparations sold over the counter) for NSAIDs other than
aspirin increased markedly in the United Kingdom from 7.6
million in 1967 to 22 million in 1985 (Walt et al., 1986). The
increase occurred in both sexes but prescription rates were
40-60% higher in women than in men throughout the
period.
Data on aspirin consumption are available from a
nationally representative survey carried out in Great Britain
in 1973 (OPCS, 1976). In this survey, women were 36% more
likely than men to have consumed any analgesics containing
aspirin in the week preceding the survey (Table I); this female
excess was particularly marked at ages 45-64 years. Among
consumers, women were also more likely to have taken these
drugs more often: 58% of women had taken these drugs at
least twice a week, whereas the corresponding figure for men
was 48%.
The increase in NSAID consumption may have contrib-
uted to the decrease in the risk of colorectal cancer in women
in England and Wales in recent years. However, the
consumption of these drugs has also increased markedly in
men (although less than in women) but no decline in their
cancer risks has yet been observed. The few analytical studies
conducted so far with sex-specific data do not seem to
indicate that the effect of these drugs on the risk of
developing colorectal cancer may be greater in women than
in men (Muscat et al., 1994; Rosenberger et al., 1991).
Table I Rates per 1000 persons taking analgesics containing aspirin
in the week preceding the survey, by sex and age (Great Britain,
1973)
Age (years)
J16 16-44 45-64 65- 74
Females 216 246 204 172
(n= 12 146)
Males 159 183 60 105
(n = 10588)
F:M ratio 1.36 1.34 3.4 1.64
Data from Office of Population Censuses and Surveys (1976).
We agree with Rettig and Lemon that further research is
needed to clarify the reasons for the observed decline in the
risk of colorectal cancer in women but not in men and, in
particular, the potential role of oral contraceptive and
NSAID use.
Isabel dos Santos Silva,
AJ Swerdlow
Epidemiological Monitoring Unit,
Department of Epidemiology and Population Sciences,
London School of Hygiene and Tropical Medicine,
Keppel Street,
London, WCJE 7HT
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